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Tools for genome engineering seem to be improving faster than computers. Just over a year ago a set of gene editing techniques—
zinc finger nucleases, transcription activator-
like effector nucleases and engineered 
meganucleases—were chosen as the method of 
the year for 2011 by the journal Nature Methods 
(Baker, 2012). The work that laid the foundations 
for zinc finger nucleases was done about 20 years 
ago, but transcription activator-like effector 
(TALE) nucleases had only emerged in 2009. 
Then, at the end of 2012, TALE nucleases were 
selected as one of the 10 breakthroughs of the 
year by the journal Science (Alberts, 2012). 
Moreover, in an article entitled ‘Genomic cruise 
missiles’, Science predicted that a new genome 
engineering technique based on the bacterial 
protein Cas9—first reported in June 2012 (Jinek 
et al., 2012)—may well replace existing techniques. 
As a cluster of papers in eLife and elsewhere 
make clear, this prediction looks to be coming 
true (Cong et al., 2013; Mali et al., 2013; 
Jinek et al., 2013).
Zinc fingers are a type of protein that binds 
to DNA and they are found in about half of all 
transcription factors in the human genome. A zinc 
finger nuclease is made by attaching a nuclease—
an enzyme that can cleave strands of DNA—to a 
zinc finger that has been re-engineered to bind to 
a particular DNA sequence (Perez-Pinera et al., 
2012). Zinc finger nucleases can, therefore, make 
precise changes to the DNA of living cells by, for 
example, knocking out a gene, correcting a genetic 
mutation or, in the presence of appropriate donor 
DNA, inserting a new gene at a specific location.
By the end of 2011, zinc finger nucleases had 
been used to knock out genes in rats, rabbits, and 
pigs, thus dethroning mice as the sole animal 
models of human genetics, and targeted gene 
disruptions had been performed on plants and 
zebrafish for the first time. Elsewhere, genetic 
manipulations of stem cells had created new ave-
nues for disease research, and there were even 
zinc finger nucleases in clinical trials. Unfortunately, 
zinc finger nucleases were also difficult to make, 
and commercial sources were expensive. More-
over, although many sequences could be targeted, 
some could not. Finally, zinc finger nucleases some-
times cleaved DNA strands in the wrong place.
The paradigm for genome engineering shifted 
seemingly overnight in late 2009 with the discovery 
that TALEs—proteins produced by Xanthamonas 
bacteria to regulate transcription in their host 
plant cells—could bind to specific regions of 
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DNA. The first TALE nuclease appeared in 2010, 
kits for their assembly appeared on the plasmid 
repository Addgene in 2011, and a method that 
can target almost 100 different genes with TALE 
nucleases was reported in April 2012 (Reyon et al., 
2012). Compared to zinc finger nucleases, TALE 
nucleases are more accurate and can cleave a 
broader, seemingly comprehensive spectrum of 
DNA sequences, which is why today most experi-
ments in genome engineering are performed 
with TALE nucleases.
Now, at the start of 2013, the paradigm seems 
set to shift again. Last year, a collaboration led by 
Jennifer Doudna of the University of California at 
Berkeley and Emmanuelle Charpentier of Umeå 
University sent shock waves through the genome 
engineering community by showing that a DNA 
nuclease called Cas9 could be targeted to spe-
cific DNA sequences if RNA was attached to it 
(Jinek et al., 2012). This new approach was 
based on the CRISPR/Cas system, which is part 
of the adaptive immune response of many bacte-
ria and archaea. When a virus or plasmid invades 
a bacterium, segments of the invader’s DNA are 
converted into CRISPR RNAs, or crRNA for short, 
by the immune response. This crRNA then associ-
ates with another type of RNA called tracrRNA to 
guide the Cas9 to a region called the ‘protospacer’ 
in the DNA of the invader. The Cas9 then cleaves 
the protospacer DNA on both strands (Figure 1). 
Importantly, Doudna, Charpentier and co-workers 
showed that the nuclease activity could be 
retargeted by simply designing a new crRNA. 
Moreover, this could be combined with the 
tracrRNA into one single-guide RNA.
Having demonstrated RNA-guided genome 
engineering in bacteria, the next challenge was to 
see if this approach would work in a eukaryotic 
nucleus. Now, in eLife, Doudna and co-workers—
including Martin Jinek as first author—show 
that it can (Jinek et al., 2013). They do this by 
infecting human cells with two plasmids, one 
expressing the Cas9 protein, the other express-
ing single-guide RNA, and showing that this 
results in the cleavage of a particular gene. Such 
components will be significantly easier to make 
than TALE nucleases. For example, a typical 
TALE nuclease requires two new protein coding 
regions, each containing about 2000 base pairs, 
to be synthesized for each new target site, and 
the highest-throughput TALE assembly systems 
require large-scale material preparation and robot-
ics for automation. In contrast, the Cas9 approach 
would require just one new RNA coding region 
of about 75 base pairs, and any investigator 
could easily order the hundreds or thousands of 
oligonucleotides needed for the experiments. 
Such ease of synthesis has enabled genome-wide 
screens of gene function using libraries of short 
hairpin RNA, so we can expect to see similar 
screens of thousands of genes with nucleases, 
possibly as soon as later this year.
Further support for this paradigm shift in 
genome engineering comes from papers by 
George Church of Harvard University and co-
workers (Mali et al., 2013) and by Feng Zhang of 
the Broad Institute and co-workers (Cong et al., 
2013). These groups demonstrated another 
advantage of CRISPR/Cas over TALE nucleases. 
Genetic deletions were produced by the simul-
taneous use of two crRNAs or single-guide RNA 
with Cas9, leading to contemporary double-
strand breaks at distant sites and loss of the inter-
vening DNA (Figure 1C). For TALE nucleases, 
such double cleavage events would require the 
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Figure 1. Jinek et al. attached a Cas9 nuclease (represented here by the purple rounded 
rectangle; the white arrows are the endonucleases) to a single-guide RNA (sgRNA), which 
guided it to a specific region of the target DNA called the protospacer. The sgRNA is a hybrid 
of two components: CRISPR RNA (crRNA; blue) and trans-activating crRNA (tracrRNA; red). 
(A) Cleavage of the target DNA by the Cas9 nuclease results in mutations that can knock out 
the target gene. (B) If an appropriate donor DNA molecule is available, genetic information 
(shown here in pale blue) can be added to the target DNA in a precise manner. (C) By 
targeting two Cas9 nucleases to different regions of the target DNA, it is possible to delete 
the genetic information between the two regions. CRISPR: clustered regularly interspaced 
short palindromic repeats; Cas: CRISPR-associated.
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synthesis of four new protein coding regions con-
taining a total of about 8000 base pairs. These 
two studies also extended the Cas9 approach to 
human induced pluripotent stem cells and mouse 
cell lines, and demonstrated alterations by both 
homologous recombination and non-homologous 
end joining mechanisms. In general, CRISPR/Cas 
systems were found to be comparable to zinc fin-
ger and TALE nucleases in terms of activity, or to 
be more active.
Many important questions still remain, such as 
the extent of ‘off-target’ events. Moreover, it 
seems that as few as 14–16 base pairs of DNA are 
actually specified by CRISPR/Cas systems, which 
is unlikely to be sufficient to define a unique 
address in a human genome. However, the new 
approach will be tested and improved at a furious 
pace in the coming months, and the Cas9 
approach may well supplant TALEs as the nucle-
ase of choice by the summer, unless there is 
another paradigm shift before then.
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